Showing results (231-240 of 325) with videos related to
Sort By:
Pageof 33
In Vivo (Athens, Greece)|September 1, 2019
Aggressive Merkel Cell Carcinoma After Janus Kinase Inhibitor Ruxolitinib for Polycythemia VeraMarco Rastrelli, Beatrice Ferrazzi, Saveria Tropea, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patientsSusanna Mandruzzato, Samantha Solito, Erika Falisi, et al.World Journal of Surgical Oncology|March 29, 2025
Completion of nodal dissection in cutaneous melanoma with metastatic sentinel nodes: Prognostic impact in a population-based cohort studyAlessandra Buja, Massimo Rugge, Chiara Trevisiol, et al.BJS Open|May 7, 2025
Excision margins and prognosis in cutaneous melanoma: retrospective population-based cohort studyAlessandra Buja, Massimo Rugge, Chiara Trevisiol, et al.Journal of Hypertension|May 11, 2006
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin IIAndrea Semplicini, Livia Lenzini, Michelangelo Sartori, et al.Frontiers in Endocrinology|April 15, 2021
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid CarcinomaSimona Censi, Loris Bertazza, Ilaria Piva, et al.BMC Cancer|November 26, 2025
Impact of comorbidities on survival in melanoma patientsAlessandra Buja, Fortunato Cassalia, Massimo Rugge, et al.Frontiers in Public Health|November 3, 2025
Healthcare costs of cutaneous melanoma according to comorbidity patterns: a population-based study from the Regional Cancer Registry of the Veneto RegionAlessandra Buja, Fortunato Cassalia, Massimo Rugge, et al.Cancer|May 10, 2023
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma IntergroupRoberto Patuzzo, Ilaria Mattavelli, Gianfranco Gallino, et al.Nutrients|October 23, 2021
Insulin/IGF-1 Signaling Is Downregulated in Barrett's Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year TrialDiletta Arcidiacono, Alice Zaramella, Federico Fabris, et al.Pageof 33